It was interesting to find that unlike GT1 and GT3 that caused endemic localized infections during decades before becoming generalized, GT4a became epidemic almost immediately after being introduced in Portugal, likely in 1980, and this epidemic may still be growing at a relatively fast rate
4 Revisiting immunotherapy for prostate cancer 4.1 Advancing immune checkpoint blockade therapy with peptide-based innovations Immunotherapy for solid tumors primarily leverages inhibitors targeting programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) and cytotoxic T lymphocyte antigen-4 (CTLA-4), collectively known as ICB (Sun et al., 2023a)
Article 7 mins Value-Led Approaches to Reduce Healthcare Costs in the U.S
Media Contact Maria Stanieich, Kyowa Hakko USA, 5514829968, [email protected] , SOURCE Kyowa Hakko USA
Data are presented as mean +/ SD, n = 3 biological replicates